Differentiating between glioblastoma (GB) with multiple foci (mGB) and multifocal central nervous system lymphoma (mCNSL) can be challenging because these cancers share several features at first appearance on magnetic resonance...
Read MoreSeveral research have indicated the significant potential of the Prognostic Nutritional Index (PNI) as a prognostic biomarker in lymphoma patients. However, there is some inconsistency in the findings of a few studies. Hence, to...
Read MoreBACKGROUND Human herpesvirus-8 (HHV-8)-associated diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS), is a rare form of lymphoid malignancy. It poses unique challenges in diagnosis in the setting of human...
Read More
The following is a summary of “Anti-RGS8 paraneoplastic cerebellar ataxia is preferentially...
Read More
1. BrECADD resulted in significantly lower treatment-related morbidity than eBEACOPP. 2....
Read More
A new risk assessment model predicts VTW, developed to address heterogeneity in lymphoma types and presentations, and the generalizability of existing models.
Read More
The following is a summary of “Epilepsy in Patients With Primary CNS Lymphoma Prevalence, Risk...
Read More
The following is a summary of “Clinical Presentation, Management, and Outcome in...
Read MoreLymphoplasmacytic lymphoma (LPL) is an incurable low-grade lymphoma with no standard therapy. Nine asymptomatic patients treated with a first-in-human, neoantigen DNA vaccine experienced no dose limiting toxicities (primary...
Read More
Click here to read this study in the NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
The following is a summary of “Evaluation of risk factors for prolonged viral shedding during...
Read More
Zanubrutinib plus venetoclax delivered promising preliminary efficacy results in newly diagnosed CLL/SLL in participants with del(17p) and/or TP53 mutations.
Read More
Patients with pre-treated relapsed or refractory follicular lymphoma have shown benefits with mosunetuzumab.
Read More
WEDNESDAY, June 26, 2024 (HealthDay News) — Glofitamab (Glofit) plus gemcitabine and...
Read More
THURSDAY, June 20, 2024 (HealthDay News) — For patients with specific subtypes of relapsed...
Read MoreResponse rates of approved systemic therapies for cutaneous T-cell lymphoma (CTCL) hover near 30%, suggesting unmet need. This study describes real-world treatment patterns and response rates of extracorporeal photopheresis...
Read More
Click here to read this study in The Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
WEDNESDAY, May 29, 2024 (HealthDay News) — Tattoo exposure is associated with an increased...
Read More
The following is a summary of “Potential Value of Ultrasound in Predicting Local...
Read More
The following is a summary of “Allogeneic hematopoietic stem cell transplantation after...
Read More
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
